Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 mai 2026 09h19 HE | Source: Research and Markets

CD73 Inhibitors Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Inhibitors by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of CD73 Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about CD73 Inhibitors...
14 mai 2026 09h17 HE | Source: Research and Markets

EpCAM-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: R&D Programs by R&D Phase and Profile of Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
14 mai 2026 09h14 HE | Source: Research and Markets

Nectin-4-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: R&D Programs by R&D Phase and Profile of Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Nectin-4-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
14 mai 2026 09h12 HE | Source: Research and Markets

Her3-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: R&D Programs by R&D Phase and Profile of Her3-targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Her3-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
14 mai 2026 07h39 HE | Source: Research and Markets

Mesothelin-Targeted Immunotherapies Pipeline Report 2026: mesothelin-targeted R&D Programs by R&D Phase in a Tabular Format and Profile of Mesothelin-targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Mesothelin-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
12 mai 2026 05h32 HE | Source: Research and Markets

CAR/TCR/TIL Therapies in Oncology Analytical Tool: Clinical Development Activity, Supported by 1,373 Clinical Trials, 350 Strategic Deals, 2,370+ Drugs, Collaborations Across 870+ Organizations

Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of CAR/TCR/TIL Therapies in Oncology with Confidence" directory has been added to ResearchAndMarkets.com's...
28 avr. 2026 04h03 HE | Source: Research and Markets

Pancreatic Neuroendocrine Tumors Market Research Report 2025-2035, Competitive Analysis of Key Players - Novartis, Pfizer, Exelixis, Merck, Ipsen Pharma, and Takeda Pharma

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Pancreatic Neuroendocrine Tumors Market - A Global and Regional Analysis: Focus on Treatment Modality, 2025-2035" report has been added to ...
28 avr. 2026 04h02 HE | Source: Research and Markets

Gastroesophageal Adenocarcinoma Market Research Report 2026, Competitive Analysis of ALX Oncology, Merck, AstraZeneca, BeOne Medicines, Taiho Pharmaceuticals, Eli Lilly - Global Forecast to 2035

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Gastroesophageal Adenocarcinoma Market - A Global and Regional Analysis: Focus on Country, 2025-2035" report has been added to ...
24 avr. 2026 06h06 HE | Source: Research and Markets

Oncology Based in-Vivo CRO Research Report 2026: $2.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology-based in-vivo CRO market is...
23 avr. 2026 04h01 HE | Source: Research and Markets

Bone Metastasis in Solid Tumors Market Research and Global Long-term Forecast Report 2025-2035 Featuring Mabwell Bioscience, Novartis, Telix Pharmaeuticals, Sichuan Kelun-Biotech

Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Bone Metastasis in Solid Tumors Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035" report has been added to ...

Page suivante